便秘(Constipation)の治療薬パイプライン動向(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Constipation - Pipeline Review, H1 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Constipation Overview 8
Therapeutics Development 9
Pipeline Products for Constipation – Overview 9
Pipeline Products for Constipation – Comparative Analysis 10
Constipation – Therapeutics under Development by Companies 11
Constipation – Therapeutics under Investigation by Universities/Institutes 13
Constipation – Pipeline Products Glance 14
Late Stage Products 14
Clinical Stage Products 15
Early Stage Products 16
Unknown Stage Products 17
Constipation – Products under Development by Companies 18
Constipation – Products under Investigation by Universities/Institutes 19
Constipation – Companies Involved in Therapeutics Development 20
AlbireoPharma 20
Astellas Pharma Inc. 21
AstraZeneca PLC 22
Beech Tree Labs, Inc. 23
Braintree Laboratories, Inc. 24
Daiichi Sankyo Company, Limited 25
Dong-A Socio Group 26
Ironwood Pharmaceuticals, Inc. 27
Kissei Pharmaceutical Co., Ltd. 28
Lipid Pharmaceuticals ehf. 29
Rhythm Pharmaceuticals 30
Sanwa Kagaku Kenkyusho Co., Ltd. 31
Shire Plc 32
SK Biopharmaceuticals Co., Ltd. 33
Sucampo Pharmaceuticals, Inc. 34
Sumitomo Dainippon Pharma Co., Ltd. 35
Synergy Pharmaceuticals, Inc. 36
Teva Pharmaceutical Industries Limited 37
Constipation – Therapeutics Assessment 38
Assessment by Monotherapy Products 38
Assessment by Target 39
Assessment by Mechanism of Action 41
Assessment by Route of Administration 43
Assessment by Molecule Type 45
Drug Profiles 47
5-BOIP – Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
ASP-7663 – Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
BLI-801 – Drug Profile 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
DA-6886 – Drug Profile 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
DS-3801 – Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
DSP-6952 – Drug Profile 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
elobixibat – Drug Profile 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
KWA-0711 – Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
linaclotide – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
LP-101 – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
lubiprostone – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
MDT-006 – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
plecanatide – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
prucalopride succinate – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
relamorelin – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
SK-1202 – Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
Small Molecule for Chronic Constipation – Drug Profile 71
Product Description 71
Mechanism of Action 71
R&D Progress 71
tenapanor hydrochloride – Drug Profile 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
Transilon – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
YKP-10811 – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
Constipation – Recent Pipeline Updates 76
Constipation – Dormant Projects 97
Constipation – Product Development Milestones 98
Featured News & Press Releases 98
Nov 20, 2014: Ironwood Earns $15 Million Milestone from Astellas upon Initiation of Enrollment in Linaclotide Phase III IBS-C Clinical Trial in Japan 98
Nov 12, 2014: Sucampo Files Patent Infringement Lawsuit Against Dr. Reddy’s 98
Nov 04, 2014: Ironwood Pharmaceuticals Initiates Phase III Trial of 72 mcg Linaclotide in Adult Patients with Chronic Idiopathic Constipation 99
Oct 24, 2014: Rhythm Presents Positive Phase 2 Study Results for Relamorelin for Chronic Constipation 99
Oct 13, 2014: Clinical Data for AMITIZA Lubiprostone to be Presented at the American College of Gastroenterology 2014 Annual Scientific Meeting 101
Oct 09, 2014: Sucampo Announces Settlement Agreement That Resolves Patent Litigation in U.S. Related to AMITIZA 102
Sep 18, 2014: Synergy Pharmaceuticals Reaches Halfway Mark for Second Pivotal Phase 3 Trial of Plecanatide in Patients with Chronic Idiopathic Constipation 103
Aug 21, 2014: Sucampo Announces New Exclusive Global Manufacturing and Supply Agreement for Lubiprostone 103
Jul 14, 2014: Synergy Pharmaceuticals Reaches Halfway Mark for the First Pivotal Phase 3 Trial of Plecanatide in Patients with Chronic Idiopathic Constipation 104
May 06, 2014: Rhythm Presents Positive GI Motility Results for Relamorelin (RM-131) in Phase 2 Chronic Constipation Study 104
Appendix 106
Methodology 106
Coverage 106
Secondary Research 106
Primary Research 106
Expert Panel Validation 106
Contact Us 107
Disclaimer 107


【レポート販売概要】

■ タイトル:便秘(Constipation)の治療薬パイプライン動向(2015年上半期版)
■ 英文:Constipation - Pipeline Review, H1 2015
■ 発行日:2015年1月22日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6050IDB
■ 調査対象地域:グローバル
  • Herpes Zoster (Shingles):グローバル臨床試験レビューH1, 2013
    Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2013" provides data on the Herpes Zoster (Shingles) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Herpes Zoster (Shingles). It includes an overview of the trial num …
  • 建築用シーラントの世界市場:シリコーンシーラント、ポリウレタンシーラント、ポリスルフィドシーラント
    The report covers the global construction sealants market and further segments the market on the basis of type, technology, application, and region. The market data for these types is given with respect to volume (thousand tons) and value ($million). The global market value of construction sealants was estimated to be about $8.93 billion in 2020 and is projected to grow at a CAGR 5.59% between 201 …
  • 世界のスマートセンサー市場動向(2012-2016)
    TechNavio's analysts forecast the Global Smart Sensor market to grow at a CAGR of 11.1 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for smart sensors in the Automotive sector. The Global Smart Sensor market has also been witnessing rapid technological advancement. However, high cost of deployment could pose a challenge to the …
  • 世界のシンフィルム(薄膜)市場動向(2012-2016)
    TechNavio's analysts forecast the Global Thin Film market to grow at a CAGR of 33.80 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing use of solar energy. The Global Thin Film market has also been witnessing various governments increasing investing in the Solar industry. However, the shortage of raw material used for the production of t …
  • セキュリティロボットの世界市場予測
    IntroductionSecurity robots are devices with locomotive capabilities, which can collect data for security purposes, and in some cases, act upon this data, if required. The information is obtained through an array of different sensors, such as ultrasonic or infrared devices, cameras, radars, and thermal sensors. Security robots have various applications in firefighting, explosive detection, rescue …
  • エアクッション包装の世界市場2019-2023
    About this market The increase in demand for secondary packaging will trigger the air cushion packaging market growth in the forthcoming years. This packaging is used for protecting and collating individual units during storage and is often used by several end-user industries including food and beverages and cosmetic sectors. This will further create a rising demand for protective packaging soluti …
  • 再発髄芽細胞腫:グローバル臨床試験レビュー(2014年上半期)
    Recurrent Medulloblastoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Recurrent Medulloblastoma Global Clinical Trials Review, H1, 2014" provides data on the Recurrent Medulloblastoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Recurrent Medulloblastoma. It includes an overview of the trial …
  • 血漿交換療法の世界市場2015-2019
    About plasma and plasma therapeutics Plasma, pale yellow in color, is the component of the blood. It acts as a medium of transportation for the blood cells and other components. It carries salts and enzymes along with water and also transports nutrients, hormones, and other substances to the different parts of the body. Plasma contains immunoglobulins, clotting factors, albumin, and other componen …
  • コンドームカテーテル(男性外部カテーテル)の世界市場
    About Male External Catheters A male external catheter, also called a condom catheter, helps drain urine without the need of catheter insertion in the urethra. It consists of a flexible sheath placed over the penis and connected by a long drainage tube that is attached to a urinary drainage bag. The sheath is usually made from latex rubber, vinyl, or silicone. It is held in place either using a do …
  • 屋外動力装置の世界市場展望2017-2026
    According to Stratistics MRC, the Global Outdoor Power Equipment Market is accounted for $20.34 billion in 2017 and is expected to reach $30.75 billion by 2026 growing at a CAGR of 4.7% during the forecast period. Increasing demand for landscaping services, growing use of power tools for construction purposes and rising in the battery-powered equipment are some of the factors fuelling the market g …
  • 世界の医薬品包装機械市場動向と予測(~2018)
    The pharmaceutical packaging equipment market has a high-growth potential owing to a majority of the drugs going off-patent in the forecast period and resultant genericization.. However, factors such as the increasing cost of raw materials, the increasingly competitive environment, the use of refurbished packaging equipment for cost-cutting activities that are preferred among smaller pharmaceutica …
  • コルチゾールの市場別医療検査数および販売予測
    This new report from Venture Planning Group provides analysis of Cortisol testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing   - Hospitals - Commercial/Private Laboratories PO …
  • 電気自動車バッテリー熱管理システムの世界市場2017-2021
    About Electric Vehicle Battery Thermal Management System The consumption of rechargeable batteries is growing globally, covering all major sectors, including consumer electronics, energy, automotive, and telecom. The efficiency of the batteries (the maximum output power with respect to size and weight) has improved due to the advances in technologies. This growth in the global rechargeable battery …
  • UCaaS(Unified Communication as a service)の世界市場(2014-2019)
    UCaaS provides integration of UC services such as telephony, unified messaging, conferencing, and collaboration platforms and applications. It provides different solutions which help businesses communicate anywhere in a cost-effective manner. For Small and medium-sized Businesses (SMBs), UCaaS can be very helpful as it helps them in saving their front-load capital and provides a per seat basis ren …
  • 世界のアナログIC市場動向(2014~2018)
    TechNavio's analysts forecast the Global Analog IC market to grow at a CAGR of 4.79 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need for power management in electronic products. The Global Analog IC market has also been witnessing the emerging applications of analog ICs in LED lighting systems. However, the demand and supply imbalance of anal …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。